We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BWIN
1151
Baldwin Insurance Group
BWIN
$2.99B
| $622K | ﹤0.01% |
12,500
| – | – |
|
1152
Fox Class A
FOXA
$27.4B
| $621K | ﹤0.01% |
14,680
-5,257
| -26% | -$204K |
|
1153
Progress Software
PRGS
$1.84B
| $621K | ﹤0.01% |
9,216
+1,500
| +19% | +$85.9K |
|
|
CVSA
1154
Covista Inc
CVSA
$4.52B
| $619K | ﹤0.01% |
8,195
| – | – |
|
1155
Rogers Corp
ROG
$2.46B
| $618K | ﹤0.01% |
5,472
| – | – |
|
1156
Yelp
YELP
$1.32B
| $617K | ﹤0.01% |
17,581
+3,900
| +29% | +$136K |
|
1157
RXO
RXO
$3.9B
| $616K | ﹤0.01% |
22,000
| – | – |
|
1158
BOK Financial
BOKF
$8.84B
| $614K | ﹤0.01% |
5,872
| – | – |
|
|
EDR
1159
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $614K | ﹤0.01% |
21,500
| – | – |
|
1160
Community Bank
CBU
$3.45B
| $611K | ﹤0.01% |
10,516
| – | – |
|
1161
Mirion Technologies
MIR
$3.89B
| $611K | ﹤0.01% |
55,231
+8,400
| +18% | +$88.4K |
|
1162
Pricesmart
PSMT
$5.54B
| $611K | ﹤0.01% |
6,658
+700
| +12% | +$60.4K |
|
1163
Concentrix
CNXC
$1.53B
| $610K | ﹤0.01% |
11,900
+3,700
| +45% | +$248K |
|
1164
Primoris Services
PRIM
$4.35B
| $610K | ﹤0.01% |
10,500
| – | – |
|
1165
Vera Therapeutics
VERA
$2.09B
| $610K | ﹤0.01% |
13,800
+2,200
| +19% | +$83.5K |
|
1166
IonQ
IONQ
$18.5B
| $605K | ﹤0.01% |
69,200
+17,200
| +33% | +$131K |
|
|
AMED
1167
DELISTED
Amedisys
AMED
| $603K | ﹤0.01% |
6,251
| – | – |
|
1168
Inter&Co
INTR
$2.32B
| $603K | ﹤0.01% |
+90,500
| New | +$625K |
|
1169
MasterBrand
MBC
$1.89B
| $603K | ﹤0.01% |
32,500
+4,000
| +14% | +$65.2K |
|
1170
Sweetgreen
SG
$719M
| $603K | ﹤0.01% |
17,000
-500
| -3% | -$15.2K |
|
1171
Kulicke & Soffa
KLIC
$4.97B
| $599K | ﹤0.01% |
13,274
| – | – |
|
1172
Cinemark Holdings
CNK
$4.35B
| $597K | ﹤0.01% |
21,432
| – | – |
|
1173
Galicia Financial Group
GGAL
$7.2B
| $596K | ﹤0.01% |
14,165
| – | – |
|
1174
Immunovant
IMVT
$8.63B
| $596K | ﹤0.01% |
20,900
+4,700
| +29% | +$139K |
|
1175
Upstart Holdings
UPST
$3.04B
| $596K | ﹤0.01% |
14,900
| – | – |
|
Similar funds
VIA
GAM
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.